Revvity, Inc. (RVTY)

業務介紹

雷維提公司(Revvity, Inc.)在全球範圍內為診斷、生命科學和應用服務市場提供產品、服務和解決方案。它通過兩個部門運營:發現和分析解決方案以及診斷。

發現和分析解決方案部門提供儀器、試劑、信息學、軟件、訂閱、檢測和成像技術,使科學家能夠在生命科學研究市場上增強研究突破,並提供合同研究和實驗室服務。它還為客戶提供分析技術、解決方案和服務,以了解包括空氣、水和土壤在內的各個方面的健康狀況。此外,該部門還為農民和食品生產商提供解決方案;為工業市場(包括化學、半導體和電子、能源、潤滑劑、石油化工和聚合物行業)提供分析儀器。

診斷部門提供儀器、試劑、測定平台和軟件產品,用於早期檢測遺傳障礙,如懷孕和幼兒,以及診斷市場上的傳染病檢測。其產品用於測試和篩查遺傳異常、障礙和疾病,包括唐氏綜合症、甲狀腺功能低下、肌肉萎縮症、不孕症和各種代謝性疾病。該部門還開發能夠支持使用蛋白偶聯受體和下一代DNA測序的基因組工作流程的技術,應用於腫瘤學、免疫診斷和藥物發現。

它為製藥和生物技術公司、實驗室、學術和研究機構、公共衛生機構、私人醫療機構、醫生和政府機構提供服務。該公司曾用名為PerkinElmer, Inc.,於2023年4月更名為Revvity, Inc.。Revvity, Inc.成立於1937年,總部位於馬薩諸塞州沃爾瑟姆。



Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

公司網址

https://www.perkinelmer.com